Searching map area
Nivolumab alone and nivolumab plus ipilimumab in recurrent small-cell lung cancer (CheckMate 032): a multicentre, open-label, phase 1/2 trial
? TBD
scientific article
Join to rate
Ratings 0
Nobody has rated this yet. Be the first!
Lists 0
Join to rate
Instance of
Scholarly article
Author
Filippo de Braud
Paolo Antonio Ascierto
T. R. Jeffry Evans
Subject
First-in-man study
Multicenter trial
phase II clinical trial
Ipilimumab
Lung cancer
References
Wikidata